Dempze Nancy E Merck & Co., Inc. Transaction History

Dempze Nancy E

$162 Million
Q3 2024

A detailed history of Dempze Nancy E transactions in Merck & Co., Inc. stock. As of the latest transaction made, Dempze Nancy E holds 10,355 shares of MRK stock, worth $1.03 Million. This represents 0.72% of its overall portfolio holdings.

Number of Shares

10,355

Previous 4,405 135.07%

Holding current value

$1.03 Million

Previous $545,000 115.6%

% of portfolio

0.72%

Previous 0.42%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$111.15 - $128.97 $661,342 - $767,371	5,950 Added 135.07%	10,355 $1.18 Million
Q2 2024 Aug 12, 2024	BUY	$123.8 - $132.96 $123,800 - $132,960	1,000 Added 29.37%	4,405 $545,000
Q1 2024 May 13, 2024	SELL	$113.24 - $131.95 $24,346 - $28,369	-215 Reduced 5.94%	3,405 $449,000
Q4 2023 Feb 13, 2024	SELL	$100.18 - $109.02 $5,009 - $5,451	-50 Reduced 1.36%	3,620 $394,000
Q3 2023 Nov 14, 2023	SELL	$102.95 - $114.33 $9,780 - $10,861	-95 Reduced 2.52%	3,670 $377,000
Q1 2022 May 17, 2022	SELL	$73.51 - $82.4 $3,454 - $3,872	-47 Reduced 1.23%	3,765 $309,000
Q4 2021 Feb 08, 2022	SELL	$72.28 - $90.54 $4,192 - $5,251	-58 Reduced 1.5%	3,812 $291,000
Q3 2021 Nov 10, 2021	SELL	$71.68 - $78.83 $10,752 - $11,824	-150 Reduced 3.73%	3,870 $291,000
Q2 2021 Aug 09, 2021	BUY	$70.31 - $77.77 $3,867 - $4,277	55 Added 1.39%	4,020 $313,000
Q1 2021 May 17, 2021	SELL	$68.86 - $81.11 $234,124 - $275,774	-3,400 Reduced 46.16%	3,965 $306,000
Q3 2020 Oct 28, 2020	SELL	$73.18 - $82.95 $32,931 - $37,327	-450 Reduced 5.76%	7,365 $611,000
Q2 2020 Jul 28, 2020	SELL	$70.42 - $80.13 $1,760 - $2,003	-25 Reduced 0.32%	7,815 $604,000
Q1 2020 May 07, 2020	SELL	$63.36 - $87.82 $7,793 - $10,801	-123 Reduced 1.54%	7,840 $603,000
Q4 2019 Jan 15, 2020	SELL	$77.58 - $87.54 $9,697 - $10,942	-125 Reduced 1.55%	7,963 $724,000
Q3 2019 Nov 07, 2019	SELL	$76.08 - $82.93 $15,216 - $16,586	-200 Reduced 2.41%	8,088 $680,000
Q2 2019 Jul 24, 2019	SELL	$69.84 - $81.59 $6,984 - $8,159	-100 Reduced 1.19%	8,288 $696,000
Q1 2019 May 01, 2019	SELL	$69.58 - $79.36 $32,493 - $37,061	-467 Reduced 5.27%	8,388 $698,000
Q4 2018 Jan 24, 2019	SELL	$65.24 - $75.71 $27,335 - $31,722	-419 Reduced 4.52%	8,855 $677,000
Q3 2018 Oct 15, 2018	SELL	$57.69 - $67.84 $576 - $678	-10 Reduced 0.11%	9,274 $658,000
Q2 2018 Jul 30, 2018	SELL	$50.83 - $59.72 $249,270 - $292,866	-4,904 Reduced 34.56%	9,284 $564,000
Q1 2018 Apr 24, 2018	SELL	$50.96 - $59.23 $15,338 - $17,828	-301 Reduced 2.08%	14,188 $773,000
Q4 2017 Feb 02, 2018	BUY	$51.62 - $61.64 $10,427 - $12,451	202 Added 1.41%	14,489 $815,000
Q3 2017 Oct 26, 2017	BUY	$58.67 - $63.13 $838,218 - $901,938	14,287	14,287 $914,000

Others Institutions Holding MRK

# of Institutions

3,820

Shares Held

1.88B

Call Options Held

15.6M

Put Options Held

13.7M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $251B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Dempze Nancy E, based on Form 13F filings with the SEC.

News

Stay updated on Dempze Nancy E with notifications on news.

Account